PUREPAC INC/
10-Q/A, 1996-03-19
PHARMACEUTICAL PREPARATIONS
Previous: IPALCO ENTERPRISES INC, 10-K, 1996-03-19
Next: FIDELITY ADVISOR SERIES VIII, 497, 1996-03-19



                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC 20549


                                 FORM 10-Q/A1

                              QUARTERLY REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

               For the Quarterly Period Ended December 31, 1995

                       Commission File Number: 0-13588



                                FAULDING INC.
             (Exact name of registrant as specified in its charter)



      DELAWARE                                           04-2769995
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                       Identification No.)


200 Elmora Avenue, Elizabeth, New Jersey                   07207
(Address of principal executive offices)                 (Zip Code)


Registrant's telephone number, including area code:      (908) 527-9100



           SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:


Title of each class                 Name of each exchange on which registered

       None                                             None 
- -------------------                              -------------------


           SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT

                    Common Stock, par value $.01 per share
                    --------------------------------------
                               (Title of class)



Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934
during the preceding twelve months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.        Yes  [X]     No  [ ]



                                  12,615,223
                                  ----------
                       Number of shares outstanding of
              the Registrant's common stock as of February 5, 1996.




                                     
<PAGE>
                                        
Item 6 (a). EXHIBITS

        EX-27:  Financial Data Schedule


<PAGE>                          


                                 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



FAULDING INC.


BY: /s/Richard F. Moldin                    March 19, 1996
    -------------------------------------
    Richard F. Moldin
    President and Chief Executive Officer
    (Principal Executive Officer)


BY: /s/Lee H. Craker                        March 19, 1996
    -------------------------------------
    Lee H. Craker
    Chief Financial Officer
    (Principal Accounting Officer)


                   


<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-END>                               DEC-31-1995
<CASH>                                             764
<SECURITIES>                                         0
<RECEIVABLES>                                    9,718
<ALLOWANCES>                                         0
<INVENTORY>                                     18,923
<CURRENT-ASSETS>                                36,750
<PP&E>                                          26,377
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  68,518
<CURRENT-LIABILITIES>                           18,189
<BONDS>                                              0
                                0
                                          8
<COMMON>                                           126
<OTHER-SE>                                      50,195
<TOTAL-LIABILITY-AND-EQUITY>                    68,518
<SALES>                                         28,689
<TOTAL-REVENUES>                                28,689
<CGS>                                           23,112
<TOTAL-COSTS>                                    9,361
<OTHER-EXPENSES>                               (1,750)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 110
<INCOME-PRETAX>                                (2,144)
<INCOME-TAX>                                     (815)
<INCOME-CONTINUING>                            (1,329)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,329)
<EPS-PRIMARY>                                    (.19)
<EPS-DILUTED>                                    (.19)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission